TABLE 4.
Risks associated with fetal and neonatal death.
| Univariate | Multivariate | |||
|  |  | |||
| Outcome | HR (95% CI) | P-value | HR (95% CI) | P-value | 
| Miscarriage | ||||
| Age (continuous) | 1.053 (1.007–1.101) | 0.02 | ||
| Age (group, years) | ||||
| <20 | 0.862 (0.359–2.069) | 0.7 | 0.755 (0.289–1.972) | 0.6 | 
| 20–35 | Reference | Reference | ||
| >35 | 2.659 (1.343–5.266) | 0.005 | 2.932 (1.477–5.819) | 0.002 | 
| Gravidity | ||||
| Primigravid | 1.070 (0.384–2.986) | 0.9 | ||
| Secundigravid | 0.603 (0.206–1.766) | 0.4 | ||
| Multigravid | Reference | |||
| Grand multigravid | 1.843 (0.943–3.604) | 0.07 | ||
| At least 1 known risk factor | 1.699 (0.905–3.190) | 0.1 | ||
| Miscarriage last pregnancy | 2.713 (1.091–6.745) | 0.03 | 3.674 (1.378–9.797) | 0.009 | 
| Stillbirth | ||||
| Age (continuous) | 1.040 (0.953–1.136) | 0.4 | 0.999 (0.897–1.113) | 0.9 | 
| Age (group) | ||||
| <20 | 0.762 (0.093–6.280) | 0.8 | ||
| 20–35 | Reference | |||
| >35 | 1.891 (0.379–9.429) | 0.4 | ||
| Gravidity | ||||
| Secundigravid | 1.211 (0.268–5.482) | 0.8 | ||
| Multigravid | Reference | |||
| Grand multigravid | 1.057 (0.200–5.583) | 0.9 | ||
| IPTp-SP doses | 0.271 (0.126–0.585) | 0.0009 | 0.245 (0.110–0.546) | 0.0006 | 
| Home delivery | 3.732 (0.780–17.860) | 0.1 | ||
| At least 1 known risk factor | 3.502 (0.965–12.700) | 0.06 | 4.088 (0.994–16.811) | 0.05 | 
| ANC visits | 0.770 (0.526–1.125) | 0.2 | ||
| Gestational age at 1st ANC | 0.937 (0.847–1.037) | 0.2 | ||
| Neonatal death | ||||
| Age (continuous) | 1.040 (0.946–1.144) | 0.4 | Model I: age and number of ANC visits 1.011 (0.909–1.23) Model II: age and number of IPTp doses 1.022 (0.926–1.129) | 0.8 0.7 | 
| Age (group) | ||||
| <20 | 2.128 (0.421–10.750) | 0.4 | ||
| 20–35 | Reference | |||
| >35 | 2.156 (0.423–11.000) | 0.4 | ||
| Gravidity | ||||
| Secundigravid | 2.173 (0.366–12.910) | 0.4 | ||
| Multigravid | Reference | |||
| Grand multigravid | 2.415 (0.517–11.290) | 0.3 | ||
| IPTp-SP doses | 0.467 (0.235–0.929) | 0.03 | Model II: age and number of IPTp doses 0.475 (0.226–0.999) | 0.049 | 
| At least 1 known risk factor | 0.805 (0.188–3.446) | 0.8 | ||
| ANC visits | 0.490 (0.276–0.868) | 0.01 | Model I: age and number of ANC visits 0.496 (0.265–0.928) | 0.03 | 
| Gestational age at 1st ANC | 1.027 (0.975–1.082) | 0.3 | ||